Semaglutide 14mg Tablets

Semaglutide 14mg is an oral GLP-1 receptor agonist used for adults with type 2 diabetes for semaglutide tablet therapy treatment. It helps the pancreas release insulin when glucose is high, lowers glucagon release, slows gastric emptying, and can reduce appetite, supporting glucose control and weight reduction in many patients. It is not insulin and is not used for type 1 diabetes or diabetic ketoacidosis. Oral semaglutide has strict administration rules because absorption is easily reduced: it is usually taken after waking on an empty stomach with a small amount of plain water, and the patient waits before eating, drinking, or taking other oral medicines according to the product plan.
Take Semaglutide 14mg exactly as prescribed, usually on waking with plain water on an empty stomach. Wait the advised time before food, drink, or other oral medicines.
Semaglutide activates GLP-1 receptors, increasing glucose-dependent insulin release, reducing glucagon, slowing gastric emptying, and reducing appetite.
Possible effects include nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, decreased appetite, and headache. Serious concerns include pancreatitis, gallbladder disease, dehydration-related kidney injury, severe allergy, retinopathy worsening, and hypoglycemia with insulin or sulfonylureas.
Review type 1 diabetes, ketoacidosis, pancreatitis, gallbladder disease, kidney disease, severe GI disease, diabetic retinopathy, pregnancy plans, breastfeeding, insulin, sulfonylureas, thyroid cancer history, and MEN2.
Type 2 diabetes mellitus in adults when oral semaglutide therapy is prescribed.
Improves glucose control through GLP-1 receptor activity and may support weight reduction in suitable adults with type 2 diabetes.
Semaglutide 14mg is used to improve glucose control in adults with type 2 diabetes for oral semaglutide treatment.
Food, drinks, and other medicines can reduce oral semaglutide absorption, so timing instructions are important.
No. It is a GLP-1 receptor agonist and is not for type 1 diabetes or diabetic ketoacidosis.
Nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, and reduced appetite can occur, especially during dose changes.
Severe persistent abdominal pain, dehydration, jaundice, severe allergy, vision changes, or neck lump/hoarseness should be reviewed urgently.
Oral semaglutide, GLP-1 receptor agonist, Type 2 diabetes medicine, Empty stomach dosing, Nausea dose escalation, Thyroid C-cell tumor warning, AR: Semaglutide أقراص, FR: Semaglutide comprimé, PT: Semaglutide comprimido, ES: Semaglutide tableta, RU: Semaglutide таблетки, ID: Semaglutide, VI: Semaglutide viên nén, MS: Semaglutide, TL: Semaglutide tableta, ZH-SG: Semaglutide 片剂
International B2B Enquiry
Send a structured B2B enquiry for Semaglutide 14mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Semaglutide 14mg Tablets